🧬 Tau Biomarker Cerebrospinal Fluid Simulator

Lumbar Puncture — Collecting Cerebrospinal Fluid

Placeholder: sterile lumbar puncture obtains CSF for biomarker testing.

• ~12 mL: Sample volume (Placeholder detail)
• L3–L4: Needle level (Placeholder detail)
• ~20 min: Procedure time (Placeholder detail)
• Headache: Common side effect (Placeholder detail)

Collection procedure placeholder heading

Placeholder: needle insertion, fluid draw, and tube handling steps summarized briefly.

Measuring Total Tau and Phospho-Tau Levels

Placeholder: immunoassays measure total tau and phosphorylated tau concentrations.

• ELISA/Simoa: Assay type (Placeholder detail)
• 100–900 pg/mL: Total tau range (Placeholder detail)
• 15–120 pg/mL: P-tau range (Placeholder detail)
• ~1–2 days: Turnaround (Placeholder detail)

Biomarker quantification placeholder heading

Placeholder: antibody-based detection quantifies tau isoforms in CSF sample.

CSF Tau/Amyloid Ratio Interpretation

Placeholder: tau-to-amyloid-beta ratio helps characterize pathology pattern.

• t-tau/Aβ42: Ratio metric (Placeholder detail)
• >0.8: High-risk ratio (Placeholder detail)
• ADNI-derived: Reference cohort (Placeholder detail)
• AD signature: Use case (Placeholder detail)

Ratio computation placeholder heading

Placeholder: combining tau and amyloid values into a single interpretive ratio.

Diagnostic Threshold Classification

Placeholder: measured biomarker levels compared against clinical cutoffs.

• ~450 pg/mL: Total tau cutoff (Placeholder detail)
• ~80 pg/mL: P-tau cutoff (Placeholder detail)
• 3 tiers: Classification bands (Placeholder detail)
• Support dx: Clinical use (Placeholder detail)

Threshold logic placeholder heading

Placeholder: cutoff bands classify results as normal, borderline, or elevated.

CSF vs Blood Biomarker Comparison

Placeholder: comparing invasive CSF testing with emerging blood-based assays.

• p-tau217: Blood assay (Placeholder detail)
• CSF > blood: Invasiveness (Placeholder detail)
• ~85–90%: Concordance (Placeholder detail)
• Blood rising: Trend (Placeholder detail)

Modality comparison placeholder heading

Placeholder: relative merits of CSF and blood-based tau biomarker testing.

Placeholder: blood-based p-tau assays may reduce reliance on lumbar puncture.